| Literature DB >> 34373564 |
Diana Prieto-Peña1, Sara Remuzgo-Martínez1, Fernanda Genre1, Verónica Pulito-Cueto1, Belén Atienza-Mateo1,2, Javier Llorca3, Belén Sevilla-Pérez4, Norberto Ortego-Centeno5, Ana Marquez6,7, Leticia Lera-Gómez1, María Teresa Leonardo8, Ana Peñalba8, Javier Narváez9, Luis Martín-Penagos10, Emilio Rodrigo10, José A Miranda-Filloy11, Luis Caminal-Montero12, Paz Collado13, Javier Sánchez Pérez14, Diego de Argila14, Esteban Rubio15, Manuel León Luque15, Juan María Blanco-Madrigal16, Eva Galíndez-Agirregoikoa16, Oreste Gualillo17, Javier Martín6, Santos Castañeda18, Ricardo Blanco1, Miguel A González-Gay1,19,20, Raquel López-Mejías21.
Abstract
Cytokines signalling pathway genes are crucial factors of the genetic network underlying the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an inflammatory vascular condition. An influence of the interleukin (IL)33- IL1 receptor like (IL1RL)1 signalling pathway on the increased risk of several immune-mediated diseases has been described. Accordingly, we assessed whether the IL33-IL1RL1 pathway represents a novel genetic risk factor for IgAV. Three tag polymorphisms within IL33 (rs3939286, rs7025417 and rs7044343) and three within IL1RL1 (rs2310173, rs13015714 and rs2058660), that also were previously associated with several inflammatory diseases, were genotyped in 380 Caucasian IgAV patients and 845 matched healthy controls. No genotypes or alleles differences were observed between IgAV patients and controls when IL33 and IL1RL1 variants were analysed independently. Likewise, no statistically significant differences were found in IL33 or IL1RL1 genotype and allele frequencies when IgAV patients were stratified according to the age at disease onset or to the presence/absence of gastrointestinal (GI) or renal manifestations. Similar results were disclosed when IL33 and IL1RL1 haplotypes were compared between IgAV patients and controls and between IgAV patients stratified according to the clinical characteristics mentioned above. Our results suggest that the IL33-IL1RL1 signalling pathway does not contribute to the genetic network underlying IgAV.Entities:
Year: 2021 PMID: 34373564 DOI: 10.1038/s41598-021-95762-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379